Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin + S-1 vs Cisplatin + Paclitaxel in Metastatic ESCC
NCT02677597Phase 3Unknown
- Sponsor
- Fudan University
- Start
- Jan 2016
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegafur in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by Fudan University. Status: unknown.
02
Drugs
tegafur
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT02677597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02677597.